NEW YORK (GenomeWeb News) – Epigenetics tools firm EpiCypher today announced it has selected Tebu-bio as its distribution partner in Europe.

Tebu-bio will distribute Research Triangle Park, NC-based EpiCypher's epigenetics and chromatic biology research products. Tebu-bio is based in Le Perray, France and has offices in Belgium, Germany, Italy, the Netherlands, Denmark, Finland, Norway, Sweden, Portugal, Spain, and the UK.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.